Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Ectonucleotidase

From Wikipedia, the free encyclopedia
Part ofa series on
Purinergic signalling
Simplified illustration of extracellular purinergic signalling
Concepts

Purinergic signalling

Membrane transporters

Nucleoside transporters

Ectonucleotidases consist of families ofnucleotidemetabolizingenzymes that are expressed on theplasma membrane and have externally oriented active sites. These enzymes metabolizenucleotides tonucleosides. The contribution of ectonucleotidases in the modulation ofpurinergic signaling depends on the availability and preference of substrates and on cell and tissue distribution.[1]

Classification

[edit]

Subfamilies of ectonucleotidases include:CD39/NTPDases (ecto-nucleotide triphosphate diphosphohydrolases), Nucleotide pyrophosphatase/phosphodiesterase (NPP)-type ecto-phosphodiesterases, alkaline phosphatases and ecto-5’-nucleotidases/CD73.[1]

Function

[edit]

Ectonucleotidases produce key molecules for purine salvage and consequent replenishment of ATP stores within multiple cell types. Dephosphorylated nucleoside derivatives interact with membrane transporters to enable intracellular uptake. Ectonucleotidases modulateP2 purinergic signaling, andP1 receptors.[2] In addition, ectonucleotidases generate extracellular adenosine, which abrogates nucleotide-mediated effects and activates adenosine receptors, often with opposing (patho-) physiological effects.[3]

Adenosine generation

[edit]

The first step in the production of adenosine involves the conversion of ATP/ADP to AMP. It is carried out byENTPD1, also known as CD39. The second step involves the conversion of AMP to adenosine. It is carried out byNT5E, also known as CD73.[4]

References

[edit]
  1. ^abBeldi, G; Enjyoji, K; Wu, Y; Miller, L; Banz, Y; Sun, X; Robson, SC (Jan 1, 2008)."The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism".Frontiers in Bioscience.13 (13):2588–603.doi:10.2741/2868.PMC 2892180.PMID 17981736.
  2. ^Kukulski, Filip; Lévesque, Sébastien A.; Sévigny, Jean (2011-01-01), Jacobson, Kenneth A.; Linden, Joel (eds.),"Chapter 9 - Impact of Ectoenzymes on P2 and P1 Receptor Signaling",Advances in Pharmacology, Pharmacology of Purine and Pyrimidine Receptors, vol. 61, Academic Press, pp. 263–299,doi:10.1016/b978-0-12-385526-8.00009-6,ISBN 9780123855268,PMID 21586362, retrieved2020-11-28
  3. ^Roberts, V; Stagg, J; Dwyer, KM (2014)."The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation".Frontiers in Immunology.5: 64.doi:10.3389/fimmu.2014.00064.PMC 3927137.PMID 24600452.
  4. ^Eltzschig, Holger K.; Bonney, Stephanie K.; Eckle, Tobias (June 2013)."Attenuating myocardial ischemia by targeting A2B adenosine receptors".Trends in Molecular Medicine.19 (6):345–354.doi:10.1016/j.molmed.2013.02.005.PMC 3674126.PMID 23540714.
Receptor
(ligands)
P0 (adenine)
P1
(adenosine)
P2
(nucleotide)
P2X
(ATPTooltip Adenosine triphosphate)
P2Y
Transporter
(blockers)
CNTsTooltip Concentrative nucleoside transporters
ENTsTooltip Equilibrative nucleoside transporters
PMATTooltip Plasma membrane monoamine transporter
Enzyme
(inhibitors)
XOTooltip Xanthine oxidase
Others
Others


Stub icon

Thisenzyme-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Ectonucleotidase&oldid=1138891394"
Categories:
Hidden category:

[8]ページ先頭

©2009-2025 Movatter.jp